Open an account

Ultralife

ULBI · NASDAQ

$6.29+$0.23 (+3.80%)TodayMarket closed ·
Prev close $6.06

About ULBI

Ultralife Corp. engages in the manufacture and sale of products for power solutions. The company is headquartered in Newark New York, New York and currently employs 678 full-time employees. Its segments include Battery & Energy Products and Communications Systems. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, thin cell and other non-rechargeable batteries, in addition to rechargeable batteries, uninterruptable power supplies, charging systems and accessories. The Communications Systems segment includes RF amplifiers, power supplies, cable and connector assemblies, amplified speakers, equipment mounts, case equipment, man-portable systems, integrated communication systems for fixed or vehicle applications and communications and electronics systems design. Its brands include Ultralife, Ultralife HiRate, Lithium Power, McDowell Research, AMTI, ABLE, ACCUTRONICS, ACCUPRO, ENTELLION, SWE Southwest Electronic Energy Group, SWE SEASAFE, among others.

Employees
678
Headquarters
Newark New York, New York
Listed
Dec 23, 1992
Sector
Industrials
Industry
Electrical Equipment
Website
ultralifecorporation.com

ULBI key statistics

Market cap
104.81M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
35.25K
Volume
42.63K
Open price
$6.07
High today
$6.43
Low today
$5.94
52 Week high
$8.25
52 Week low
$4.90

Ultralife (ULBI) at a glance

As of Oct 20, 2026, Ultralife (ULBI) shares are priced at $6.29, giving the company a market cap of 104.81M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $5.94 and $6.43. The current price is 5.9% above the day's low and 2.2% below its high.

Volume so far is 42.63K shares, above the average of 35.25K shares a day.

Over the past year Ultralife has ranged from $4.90 to $8.25, and now sits 41% of the way up that range.

Ultralife met or beat analyst EPS estimates in 1 of the last 8 quarters. In Q1 FY26 it reported -$0.03 per share against an estimate of $0.1632.

ULBI earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 1 of the last 8 quarters, by 54.1% on average.

  1. Q2 FY24: reported $0.22 per share against an estimate of $0.1428
  2. Q3 FY24: reported $0.02 per share against an estimate of $0.2142
  3. Q4 FY24: reported $0.01 per share against an estimate of $0.153
  4. Q4 FY25: reported $0.12 per share against an estimate of $0.2754
  5. Q1 FY25: reported $0.13 per share against an estimate of $0.153
  6. Q2 FY25: reported $0.07 per share against an estimate of $0.1428
  7. Q3 FY25: reported -$0.07 per share against an estimate of $0.2244
  8. Q1 FY26: reported -$0.03 per share against an estimate of $0.1632

ULBI news

  • Earnings Preview For Ultralife

  • 12 Industrials Stocks Moving In Thursday's Intraday Session

  • 12 Industrials Stocks Moving In Thursday's Pre-Market Session

  • Examining the Future: Ultralife's Earnings Outlook

  • Rishabh Mishra

    US Stocks Likely To Open Mixed After Disappointing Q1 Performance: 'April Does Better After A Weak Q1,' Says Expert

  • Avi Kapoor

    Dow Surges Over 400 Points But Records Losses For March: Greed Index Remains In 'Extreme Fear' Zone

  • Avi Kapoor

    XPeng, Ultralife And 3 Stocks To Watch Heading Into Tuesday

  • 12 Industrials Stocks Moving In Friday's Pre-Market Session

Similar companies

Companies in the same industry as Ultralife

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.